Événements
AASLD 2020
13-16 Novembre 2020
Edition virtuelle
ENYO Pharma était connectée à l’édition virtuelle du AASLD meeting 2020.
Ce meeting confirme que vonafexor (EYP001, FXRAg) a un postionnement unique pour HBV et peut se différentier dans la NASH avec des phases 2 en bonne voie pour livrer des résultats au 1er semestre 2021.
Nous avons aussi présenté un poster décrivant une nouvelle petite molécule modulatrice des protéines mitochondriales NEET qui améliore l’inflammation et la fibrose dans le foie et les reins de souris NASH :
American Society of Nephrology – Kidney Week 2020
ENYO Pharma is present at the digital Kidney Week 2020 organized by the ASN with a poster. ASN has been honored to host the world’s premier meeting in nephrology for 50+ years, which has been “Reimagined” as a fully digital meeting.
“A novel small molecule modulating the mitochondrial NEET proteins improves inflammation and fibrosis in kidneys of NASH mice”
Selection pour le board internation de MATWIN
Meeting virtuel
13-14 Octobre, 2020
MATWIN (Maturation & Accelerating Translation within Industry) is an innovation platform that aims to accelerate transfer of oncology innovation from academia & SMEs to clinical development. 13 Pharma partners and numerous academic opinion leaders review proposals for partnership opportunities that offer most promise for patient well being. ENYO Pharma project is selected for a pitch to participating VC investors for start-up funds.
EASL – The Digital International Liver Congress 2020
27-29 août 2020
Congrès virtuel
ENYO Pharma était présente du 27 au 29 août 2020 au congrès virtuel international sur le foie (EASL) et a présenté 2 posters :
“Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”
“A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”
J.P. Morgan 2020 – 38th Annual Healthcare Conference
13 – 16 January, 2020
San Francisco, USA
“ENYO Pharma team was present at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.”
Dernière press release 